These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Long-term management of acquired thrombotic thrombocytopenic purpura using serial plasma ADAMTS13 measurements. Knovich MA, Farland A, Owen J. Eur J Haematol; 2012 Jun 01; 88(6):518-25. PubMed ID: 22324373 [Abstract] [Full Text] [Related]
8. Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura. Tsai HM, Shulman K. Eur J Haematol; 2003 Mar 01; 70(3):183-5. PubMed ID: 12605663 [Abstract] [Full Text] [Related]
9. Successful management of thrombotic thrombocytopenic purpura in a Jehovah's Witness without plasma exchange. Chai W, Chaudhry A, Rabinowitz AP. J Clin Apher; 2015 Feb 01; 30(1):46-9. PubMed ID: 24782109 [Abstract] [Full Text] [Related]
10. Rituximab for the treatment of thrombotic thrombocytopenic purpura in systemic lupus erythematosus. Limal N, Cacoub P, Sène D, Guichard I, Piette JC. Lupus; 2008 Jan 01; 17(1):69-71. PubMed ID: 18089688 [No Abstract] [Full Text] [Related]
11. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP). Ahmad A, Aggarwal A, Sharma D, Dave HP, Kinsella V, Rick ME, Schechter GP. Am J Hematol; 2004 Oct 01; 77(2):171-6. PubMed ID: 15389904 [Abstract] [Full Text] [Related]
12. [Rituximab as effective therapy in very severe thrombotic thrombocytopenic purpura (TTP)]. Illner N, Wolf G. Dtsch Med Wochenschr; 2010 May 01; 135(3):71-4. PubMed ID: 20077379 [Abstract] [Full Text] [Related]
13. Refractory thrombotic thrombocytopenic purpura and membranoproliferative glomerulonephritis successfully treated with rituximab: a case associated with hepatitis C virus infection. Mak SK, Lo KY, Lo MW, Chan SF, Lo KC, Wong YY, Tong GM, Wong PN, Ma ES, Wong AK. Hong Kong Med J; 2009 Jun 01; 15(3):201-8. PubMed ID: 19494376 [Abstract] [Full Text] [Related]
14. Recent advances in thrombotic thrombocytopenic purpura. Sadler JE, Moake JL, Miyata T, George JN. Hematology Am Soc Hematol Educ Program; 2004 Jun 01; ():407-23. PubMed ID: 15561695 [Abstract] [Full Text] [Related]
15. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies. Bresin E, Gastoldi S, Daina E, Belotti D, Pogliani E, Perseghin P, Scalzulli PR, Paolini R, Marcenò R, Remuzzi G, Galbusera M. Thromb Haemost; 2009 Feb 01; 101(2):233-8. PubMed ID: 19190804 [Abstract] [Full Text] [Related]
16. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other? Shibagaki Y, Fujita T. Hypertens Res; 2005 Jan 01; 28(1):89-95. PubMed ID: 15969259 [Abstract] [Full Text] [Related]
17. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases. Fakhouri F, Vernant JP, Veyradier A, Wolf M, Kaplanski G, Binaut R, Rieger M, Scheiflinger F, Poullin P, Deroure B, Delarue R, Lesavre P, Vanhille P, Hermine O, Remuzzi G, Grünfeld JP. Blood; 2005 Sep 15; 106(6):1932-7. PubMed ID: 15933059 [Abstract] [Full Text] [Related]
18. [Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange]. Koshino M, Kudou D, Okoshi Y, Obara N, Simizu S, Mukai HY, Suzukawa K, Hasegawa Y, Kojima H, Nagasawa T, Chiba S. Rinsho Ketsueki; 2010 Feb 15; 51(2):127-31. PubMed ID: 20379104 [Abstract] [Full Text] [Related]
19. ADAMTS13 deficiency and thrombotic thrombocytopenic purpura associated with trimethoprim-sulfamethoxazole. Bapani S, Epperla N, Kasirye Y, Mercier R, Garcia-Montilla R. Clin Med Res; 2013 Jun 15; 11(2):86-90. PubMed ID: 23262188 [Abstract] [Full Text] [Related]
20. Hereditary thrombotic purpura. Khan MR, Ashraf MS. J Pak Med Assoc; 2014 Feb 15; 64(2):217-9. PubMed ID: 24640819 [Abstract] [Full Text] [Related] Page: [Next] [New Search]